These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34669552)

  • 1. President's message.
    Kushner MD; Balsara S
    J Addict Dis; 2021; 39(4):433-435. PubMed ID: 34669552
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients With Opioid Use Disorder Deserve Trained Providers.
    Weimer MB; Tetrault JM; Fiellin DA
    Ann Intern Med; 2019 Dec; 171(12):931-932. PubMed ID: 31766053
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic.
    Nguyen TD; Gupta S; Ziedan E; Simon KI; Alexander GC; Saloner B; Stein BD
    JAMA Intern Med; 2021 Apr; 181(4):562-565. PubMed ID: 33346795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
    Doernberg M; Krawczyk N; Agus D; Fingerhood M
    Subst Abus; 2019; 40(2):148-153. PubMed ID: 31008694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
    McBain RK; Dick A; Sorbero M; Stein BD
    Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
    [No Abstract]   [Full Text] [Related]  

  • 6. Buprenorphine unobserved "home" induction: a survey of Ontario's addiction physicians.
    Srivastava A; Kahan M; Leece P; McAndrew A
    Addict Sci Clin Pract; 2019 May; 14(1):18. PubMed ID: 31039821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and abuse of opioids. President's message.
    Lande RG
    J Addict Dis; 2010 Oct; 29(4):502-3. PubMed ID: 20924888
    [No Abstract]   [Full Text] [Related]  

  • 8. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
    Peterson LE; Morgan ZJ; Eden AR
    J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters.
    Quest TL; Merrill JO; Roll J; Saxon AJ; Rosenblatt RA
    J Opioid Manag; 2012; 8(1):29-38. PubMed ID: 22479882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage.
    Barsky BA; Busch AB; Patel SY; Mehrotra A; Huskamp HA
    JAMA Netw Open; 2022 Jan; 5(1):e2142531. PubMed ID: 34989798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. President's message. The perfect storm: Substance Abuse and Mental Health Services Administration (SAMHSA) Buprenorphine notice of proposed rule-making (NPRM).
    Morrone WR
    J Addict Dis; 2016; 35(2):157-8. PubMed ID: 27049548
    [No Abstract]   [Full Text] [Related]  

  • 12. Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California.
    Herring AA; Kalmin M; Speener M; Goodman-Meza D; Snyder H; Campbell A; Moulin A; Shoptaw S
    J Subst Abuse Treat; 2021 Apr; 123():108260. PubMed ID: 33612194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response: integrating buprenorphine therapy into clinical practice.
    Doot MC; Payte JT; Van Zee A
    Sci Pract Perspect; 2004 Aug; 2(2):20-3. PubMed ID: 18552730
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends In Buprenorphine Prescribing By Physician Specialty.
    Wen H; Borders TF; Cummings JR
    Health Aff (Millwood); 2019 Jan; 38(1):24-28. PubMed ID: 30615523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. President's message.
    Kushner MD; Rylaarsdam A
    J Addict Dis; 2021; 39(3):285-287. PubMed ID: 34024267
    [No Abstract]   [Full Text] [Related]  

  • 17. Doing our part to dismantle the opioid crisis.
    Hickner J
    J Fam Pract; 2019; 68(6):308. PubMed ID: 31381618
    [No Abstract]   [Full Text] [Related]  

  • 18. New Jersey Physicians' Response to the Opioid Epidemic.
    Farber NI; Povolotskiy R; Roy SC; Grube JG; Baredes S; Eloy JA
    MD Advis; 2020; 13(3):12-16. PubMed ID: 33352028
    [No Abstract]   [Full Text] [Related]  

  • 19. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
    Chou R; Ballantyne J; Lembke A
    Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
    [No Abstract]   [Full Text] [Related]  

  • 20. Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey.
    Lowenstein M; Kilaru A; Perrone J; Hemmons J; Abdel-Rahman D; Meisel ZF; Delgado MK
    Am J Emerg Med; 2019 Sep; 37(9):1787-1790. PubMed ID: 30803850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.